ContractClinical Trial Agreement • June 17th, 2022
Contract Type FiledJune 17th, 2022AMENDMENT No. 1 TO CLINICAL TRIAL AGREEMENT DODATEK č. 1 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ This Amendment to Clinical Trial Agreement (“Amendment”) is between: Fakultní nemocnice Olomouc, having a place of business at I. P. Pavlova 185/6, 779 00 Olomouc, Czech Republic, Identification number: 00098892, Tax identification number: CZ00098892, represented by prof. MUDr. Roman Havlík, Ph.D., Director (the “Institution”); and (the “Investigator”); and IQVIA RDS Czech Republic s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8 - Karlín, Czech Republic, Identification number: 24768651, Tax identification number: CZ24768651, (“IQVIA”); and GlaxoSmithKline Research and Development Limited, having a place of business at 980 Great West Road, Brentford, Middlesex, TW8 9GS, England, Identification number: 00835139, Tax identification number: 2017061341 (“Sponsor”)and is effective as of its publication in the Register of Agreements, but the parties agree to be bound by the rig